.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

VISICOL Drug Profile

« Back to Dashboard
Visicol is a drug marketed by Salix Pharms and is included in one NDA.

The generic ingredient in VISICOL is sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate. There are one thousand three hundred and twenty-nine drug master file entries for this compound. Additional details are available on the sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate profile page.

Summary for Tradename: VISICOL

Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details

Clinical Trials for: VISICOL

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Salix Pharms
VISICOL
sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate
TABLET;ORAL021097-001Sep 21, 2000DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VISICOL

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Salix Pharms
VISICOL
sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate
TABLET;ORAL021097-001Sep 21, 20005,616,346<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc